GALILEE, Israel--(BUSINESS WIRE)--MIGAL Galilee Research Institute, an applied research organization and technology accelerator specializing in the fields of agrotechnology, metabolic engineering, clinical nutrition, nutrition sciences, biotechnology, food technology, environmental and computer sciences - announced today the establishment of the first specialized Agro-Biomedical hub.
The Agro-Biomedical center encompasses the entire development chain from the bench to the growers.
Earlier this week MIGAL organized and hosted a multi-faceted conference bringing together under one roof for the first time agriculturists, agro experts, agrotechnologists, experts in nutrition science and functional food, clinical nutritionists, entrepreneurs, startup companies, nutraceuticals companies, angel investors, venture capitalists, representatives of the global food industry, parliament members, government officials and global pharma.
About the Agro-Biomedical center
The center shall serve as a hub for applied researchers, clinicians, entrepreneurs, startups, growers and consumer companies specializes in functional foods, food supplements, nutraceuticals, novel botanical therapeutics and related agrotech technologies. Research at the center is focused on Natural Products and Metabolic Engineering. The center is located in one of the world's most developed agro regions. Supported by strong national initiative a new technology incubator of a national scope is going to be established beside the center.
The newly established center of excellence will become a home for Research-Entrepreneurs who wish to enjoy both worlds. Leading excellent research and taking part in building an industry. MIGAL encourages leading researchers to become involved in high quality translational research and the opportunity to join R&D efforts based on their work. The center also serves as an accelerator – promoting the early development of novel Agro-Biomedical technologies. Together with its industry partners the MIGAL accelerator will support the development of a leading Agro-Biomedical industry in the Galilee.
Avishai Levy, Chief Executive Officer of MIGAL Galilee Research Institute, said: "The newly established Agro-Biomedical center is being built up on our ability to create and foster partnerships, our interdisciplinary culture, successful collaborations and expertise in agriculture, metabolic engineering, agrotechnology, clinical nutrition and computational sciences. We are very excited about our recent achievement to bring together under one roof for the first time senior representatives from the global pharma industry, the food industry, Venture Capitalists, parliament members and traditional farmers. We hope that the meeting will trigger processes that will support the development of the field and create new opportunities for partnership between disciplines that so far didn’t think they have too much in common. One of our roles in this center is to assist in building up these collaborations."
About MIGAL
Located in a unique countryside area thirty minutes from the Sea of Galilee, MIGAL is internationally recognized as a hub of agro-innovation and metabolic engineering. Our scientists hold unique expertise in plant-based platforms to produce therapeutic molecules, chemical extractions, vaccines technologies and computational chemistry.
Research in MIGAL is highly interdisciplinary combining expertise in Metabolic engineering, clinical nutrition, plant sciences, chemistry, computational chemistry, biochemistry and microbiology. We also have an in-house R&D unit of about 50 agro-researchers and technicians working in 10 experimental farms at various topographies and climates. This agro R&D unit known as "Northern R&D" enables us to execute research programs that go all the way from the bench to the field. MIGAL forms the basis for a large number of agro-innovation and BioMed projects, some are marketed products and some others ended up as successful, publicly traded, biotech companies.
MIGAL offers a unique opportunity for leading researchers who wish to become involved in translational research and later on in R&D efforts based on their work. Our Research-Entrepreneurs program ("R/E's") enable researchers to pursue high-risk commercialization oriented projects. This program is strongly supported by MIGAL's business unit.
For more information on MIGAL Galilee Research Institute, please visit www.migal.org.il.
